1063-1070
Review Article
Blood−brain barrier transporters and response to CNS-active drugs
Bradley L. Urquhart and Richard B. Kim
1071-1080
Review Article
Statins and total (not LDL) cholesterol concentration and outcome of myocardial infarction: results from a meta-analysis and an observational study
Xia Sheng, Li Wei, Michael J. Murphy and Thomas M. MacDonald
1081-1088
Clinical Trial
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors
Todd Hulgan, John P. Donahue, Laura Smeaton, Minya Pu and Hongying Wang, et al.
1089-1096
Clinical Trial
Nurse-led medication reviews and the quality of drug treatment of elderly hospitalized patients
Monica Bergqvist, Johanna Ulfvarson and Eva Andersén Karlsson
1097-1103
Pharmacogenetics
Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients
Masako Ohno, Akiko Yamamoto, Ayumu Ono, Genta Miura and Masanobu Funamoto, et al.
1105-1112
Pharmacokinetics and Disposition
The development of an objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leukaemia—an exploratory study
Ahmed F. Hawwa, Jeff S. Millership, Paul S. Collier, Anthony McCarthy and Sid Dempsey, et al.
1113-1120
Pharmacokinetics and Disposition
Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study
Richard Hallinan, Séverine Crettol, Kingsley Agho, John Attia and Jacques Besson, et al.
1121-1130
Pharmacokinetics and Disposition
Population pharmacokinetics of recombinant factor VIII:C (ReFacto®) in adult HIV-negative and HIV-positive haemophilia patients
Anastasia Karafoulidou, Elena Suarez, Ioanna Anastasopoulou, Olga Katsarou and Anna Kouramba, et al.
1131-1138
Pharmacoepidemiology and Prescription
Antidepressants and cardiovascular outcomes in patients without known cardiovascular risk
Simona Monte, Alejandro Macchia, Marilena Romero, Antonio D’Ettorre and Rachele Giuliani, et al.
1139-1147
Pharmacoepidemiology and Prescription
Open AccessThe use of driving impairing medicines: a European survey
Silvia Ravera, Sylvia A. Hummel, Pieter Stolk, Rob E. Heerdink and Lolkje T. W. de Jong–van den Berg, et al.
1149-1157
Pharmacoepidemiology and Prescription
Successful strategy to improve the specificity of electronic statin–drug interaction alerts
Hanna Marita Seidling, Caroline Henrike Storch, Thilo Bertsche, Christian Senger and Jens Kaltschmidt, et al.
1159-1160
Letter to the Editors
Open AccessIndividualized dosing of aminoglycosides in neonates: mission accomplished or work in progress?
John N. van den Anker and Karel Allegaert
1161
Letter to the Editors
Prognostic value of the quality indicator “concurrent use of three or more psychotropic drugs” among residents of long-term care facilities: a comment
Eva Lesén, Max Petzold, Karolina Andersson and Anders Carlsten
1163-1164
Letter to the Editors
Prognostic value of the quality indicator “concurrent use of three or more psychotropic drugs” among residents of long-term-care facilities
J. Simon Bell, Heidi T. Taipale, Helena Soini and Kaisu H. Pitkälä
1165-1166
Letter to the Editors
Seretide withdrawal increases airway inflammation in moderate COPD patients
Zoe Borrill, Kay Roy, Umme Kolsum, Tom Southworth and Jorgen Vestbo, et al.
1167-1168
Letter to the Editors
Protopathic bias in observational studies on statin effectiveness
Maarit Jaana Korhonen, Risto Huupponen, Päivi Ruokoniemi and Arja Helin-Salmivaara